Debt-to-equity in % of Coya Therapeutics, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Coya Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q3 2023 to Q3 2025.
Coya Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 15%, a 10% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Coya Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	15%	+1%	+10%	30 Sep 2025
Q2 2025	14%	-1%	-8.1%	30 Jun 2025
Q1 2025	13%	-2%	-14%	31 Mar 2025
Q4 2024	13%	0%	-2.1%	31 Dec 2024
Q3 2024	14%	-54%	-79%	30 Sep 2024
Q2 2024	15%			30 Jun 2024
Q1 2024	15%			31 Mar 2024
Q4 2023	13%			31 Dec 2023
Q3 2023	68%			30 Sep 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.